In data of the Look AHEAD trial, the effects on CV risk factors of maintaining weight loss were compared with those of weight regain, in year 1 to 4 after a 1-year intensive lifestyle intervention.
Data of the Framingham Original and Offspring Cohorts show that parental smoking during childhood is associated with a higher AF risk, partly because offspring show higher propensity of smoking.
A meta-analysis of 15 studies with more than 220,000 individuals showed that a mindset of optimism was associated with reduced risk of CV events and all-cause mortality.
Apple will conduct three health studies, among which the Heart and Movement Study, in partnership with AHA and Brigham and Women’s Hospital, by using the new Research app.
EPCCS Council members convened in Bucharest, Romania, to evaluate EPCCS’s current activities and move them forward to increasingly support GP’s across Europe in their daily clinical practice.
Prof. Christos Lionis gives a brief impression of how EPCCS activities and plans can be useful for primary care physicians.
Drs. Cormac O'Dubhghaill (Ireland) and Zehra Daghli (Turkey), two country representatives in the EPCCS Council, summarise the proposed ambitions and plans to increase the outreach of EPCCS to European primary care doctors.
Large community-based study with repeated weight and height measurements shows that long-term obesity and change in BMI over time are more informative to assess AF risk than current weight.
EASD 2019 Study shows that both natural variation in ACE concentrations and lowering blood pressure with ACE inhibitors are associated with lower risk of type 2 diabetes.
EASD 2019 The VERIFY trial demonstrated that early combination therapy using vildagliptin and metformin was superior to a sequential approach involving later intensification in new T2DM
Data of US postmenopausal women with normal BMI show that trunk fat and higher leg fat have opposing associations with CVD risk, while total body fat was not significantly related to CVD risk.
ESC 2019 Contrary to the hypothesis that ticagrelor would be superior, a prasugrel-based strategy reduced ischemic endpoints as compared with ticagrelor, without an increased bleeding risk.